Groupon Inc. (NASDAQ:GRPN): Current price $9.44
On Monday, Groupon launched the Groupon Partner Network, representing the first proprietary local e-commerce affiliate marketing platform created to assist online publishers in better monetizing their online presence via the promotion of Groupon deals. Through retargeting and an extensive array of publishing tools, the network distributes Groupon deals with the most relevance across partner websites and applications, helping increase the visibility and distribution of merchants’ deals and driving purchases through the firm.
Intel Corp. (NASDAQ:INTC): Current price $22.53
Intel shares are up almost 3 percent Monday after an upgrade by analyst Auguste Richard at Piper Jaffray. Richard believes that Intel could benefit as firms begin to purchase more PCs in next few months, as the release of a new version of Windows in the fourth quarter, together with the end of support for Windows XP in April, is likely to bring about a slight upturn in PC sales. Richard wrote that Intel’s new Bay Trail chip, which is “good enough” for consumer tablets, should help as well; he expects Intel’s revenue to increase by about 5 percent in 2014.
GTx Inc. (NASDAQ:GTXI): Current price $1.49
GTx shares are down over 63 percent Monday after the firm said that its experimental drug to treat muscle wasting in cancer patients was ineffective in improving body mass in late-stage trials. A 3 mg dose of the drug, enobosarm, was tested on 650 patients with non-small cell lung cancer, the most common form of the disease. Presently, there is no approved cure for cancer-induced muscle wasting, which leads to decreased physical function, fatigue, and weight loss.